Literature DB >> 20837367

Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study).

Alberto García-Castelo1, Javier García-Seara, Fernando Otero-Raviña, Manuel Lado, Andrés Vizcaya, Juan M Vidal, Ramón Lafuente, David Bouza, Pamela V Lear, José R González-Juanatey.   

Abstract

INTRODUCTION: The aim of the study is to describe the natural history of an unselected population of patients with atrial fibrillation (AF) currently attending primary care services in a single health-service area in Galicia, north-western Spain.
METHODS: AFBAR is a transverse prospective study in which 35 general practitioners within one health-service area have enrolled patients diagnosed with AF who presented at their clinics during a three-month recruiting period. Primary endpoints are mortality or hospital admission. Here we report the results of the first 7-month follow-up period.
RESULTS: 798 patients (421 male) were recruited; mean age of cohort was 75 years old. Hypertension was the most prevalent risk factor (77%). 87% of the patients were both overweight and obese. Permanent AF was diagnosed in 549 patients (69%). In the follow-up period, 16.4% of the patients underwent a primary endpoint and the overall survival was 98%. The following independent determinants of primary endpoint were identified: change in AF status (Hazard Ratio (HR) 2.89 (95% confidence interval (CI) 1.28-6.55); p=0.011); ischemic heart disease (IHD) (HR 2.78 (95% CI 1.51-5.13); p=0.001); pre-recruitment hospital admission (HR 2.22 (95% CI 1.18-4.19); p=0.013); left ventricular systolic dysfunction (HR 2.19 (95% CI 1.11-4.32); p=0.023); or AF-related complications (HR 1.98 (95% CI 1.10-3.56); p=0.022).
CONCLUSIONS: In the first 7-month follow-up period of patients with AF in a primary care setting the study identified several independent risk factors for mortality or hospital admission, i.e. change in AF status, ischemic heart disease, left ventricular systolic dysfunction, previous AF-related complications and hospital admission.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20837367     DOI: 10.1016/j.ijcard.2010.08.042

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Exploring The Obesity Paradox In Atrial Fibrillation. AFBAR (Atrial Fibrillation Barbanza Area) Registry Results.

Authors:  M Cristina González-Cambeiro; Emad Abu-Assi; Sergio Raposeiras-Roubín; Moisés Rodríguez-Mañero; Fernando Otero-Raviña; José R González-Juanatey; Genaro Gutiérrez-Fernández; Rosa Liñares-Stolle; Jorge Alvear-García; Mª Jesús Eirís-Cambre; Carmen Cerqueiras-Alcalde; Mª José Vázquez López; Ángel Lado-Llerena
Journal:  J Atr Fibrillation       Date:  2014-02-28

2.  Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban.

Authors:  Jen-Hung Huang; Yung-Kuo Lin; Cheng-Chih Chung; Ming-Hsiung Hsieh; Wan-Chun Chiu; Yi-Jen Chen
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-24       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.